Esperion Therapeutics Inc Sustainability Reports
Esperion Therapeutics, Inc. is a pharmaceutical company that focuses on developing and commercializing oral therapies for patients with elevated low-density lipoprotein cholesterol levels. Its marketed products include bempedoic acid-based therapies such as Nexletol and Nexlizet.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300OFU56UKEWVUS92
5 reports from 2016 to 2024
